Search

Author/Creator Moris, Philippe

1. Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study. (September 2016)

Authors:
Gillard, Paul; Yang, Pan-Chyr; Danilovits, Manfred; Su, Wei-Juin; Cheng, Shih-Lung; Pehme, Lea; Bollaerts, Anne; Jongert, Erik; Moris, Philippe; Ofori-Anyinam, Opokua; Demoitié, Marie-Ange; Castro, Marcela
Journal:
Tuberculosis
Issue:
Volume 100(2016)
Page Start:
118
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial. Issue 41 (24th September 2019)

Authors:
Wilkinson, Tom M.A.; Schembri, Stuart; Brightling, Christopher; Bakerly, Nawar D.; Lewis, Keir; MacNee, William; Rombo, Lars; Hedner, Jan; Allen, Martin; Walker, Paul P.; De Ryck, Iris; Tasciotti, Annaelisa; Casula, Daniela; Moris, Philippe; Testa, Marco; Arora, Ashwani K.
Journal:
Vaccine
Issue:
Volume 37:Issue 41(2019)
Page Start:
6102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. (3rd February 2019)

Authors:
Folschweiller, Nicolas; Behre, Ulrich; Dionne, Marc; Durando, Paolo; Esposito, Susanna; Ferguson, Linda; Ferguson, Murdo; Hillemanns, Peter; McNeil, Shelly A; Peters, Klaus; Ramjattan, Brian; Schwarz, Tino F; Supparatpinyo, Khuanchai; Suryakirian, Pemmaraju V; Janssens, Michel; Moris, Philippe; D...
Journal:
Journal of infectious diseases
Issue:
Volume 219:Number 11(2019)
Page Start:
1799
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions. Issue 9 (2nd September 2019)

Authors:
Moris, Philippe; Bauer, Kristen M.; Currier, Jeffrey R.; Friberg, Heather; Eckels, Kenneth H.; Esquilin, Ines O.; Gibbons, Robert V.; Innis, Bruce L.; Jarman, Richard G.; Simasathien, Sriluck; Sun, Peifang; Thomas, Stephen J.; Watanaveeradej, Veerachai
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 15:Issue 9(2019)
Page Start:
2090
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults. Issue 3 (January 2016)

Authors:
Kumarasamy, Nagalingeswaran; Poongulali, Selvamuthu; Bollaerts, Anne; Moris, Philippe; Beulah, Faith Esther; Ayuk, Leo Njock; Demoitié, Marie-Ange; Jongert, Erik; Ofori-Anyinam, Opokua
Other Names:
Sowah. Leonard Anang section editor.
Journal:
Medicine
Issue:
Volume 95:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study. (September 2016)

Authors:
Gillard, Paul; Yang, Pan-Chyr; Danilovits, Manfred; Su, Wei-Juin; Cheng, Shih-Lung; Pehme, Lea; Bollaerts, Anne; Jongert, Erik; Moris, Philippe; Ofori-Anyinam, Opokua; Demoitié, Marie-Ange; Castro, Marcela
Journal:
Tuberculosis
Issue:
Volume 100(2016)
Page Start:
118
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults. Issue 3 (January 2016)

Authors:
Kumarasamy, Nagalingeswaran; Poongulali, Selvamuthu; Bollaerts, Anne; Moris, Philippe; Beulah, Faith Esther; Ayuk, Leo Njock; Demoitié, Marie-Ange; Jongert, Erik; Ofori-Anyinam, Opokua
Editors:
Sowah., Leonard Anang
Journal:
Medicine
Issue:
Volume 95:Issue 3(2016)
Page Start:
e2459
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial. Issue 4 (15th January 2015)

Authors:
Langley, Joanne M.; Frenette, Louise; Jeanfreau, Robert; Halperin, Scott A.; Kyle, Michael; Chu, Laurence; McNeil, Shelly; Dramé, Mamadou; Moris, Philippe; Fries, Louis; Vaughn, David W.
Journal:
Vaccine
Issue:
Volume 33:Issue 4(2015)
Page Start:
559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials. Issue 4 (15th January 2015)

Authors:
Leroux-Roels, Isabel; Devaster, Jeanne-Marie; Leroux-Roels, Geert; Verlant, Vincent; Henckaerts, Isabelle; Moris, Philippe; Hermand, Philippe; Van Belle, Pascale; Poolman, Jan T.; Vandepapelière, Pierre; Horsmans, Yves
Journal:
Vaccine
Issue:
Volume 33:Issue 4(2015)
Page Start:
577
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗